Paper Details

  1. Home
  2. Paper Details

Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders.

Author: GenoveseAnn, HellingsJessica A, JadhavMandar, JadhavSneha, JainSeema

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

This study examines the neuromotor tolerability of low-dose loxapine (LOX) in an outpatient sample of adolescents and adults with autism spectrum disorders (ASD). LOX has shown promise in previous studies for improving behavior and maintaining weight neutrality in individuals with ASD.
Paper Details　
Original Abstract of the Article :
New and repurposed drugs are urgently needed to treat individuals with autism spectrum disorders (ASD). Loxapine (LOX) in low doses of 5-15 mg/day resembles an atypical antipsychotic (Stahl 2002 ). Our recent open pilot study of LOX found significant behavioral improvements and overall weight neutra...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1089/cap.2014.0145

データ提供：米国国立医学図書館（NLM）

Unlocking the Potential of Loxapine for Autism Spectrum Disorders

The search for effective treatments for autism spectrum disorders (ASD) is like traversing a vast and unknown desert. This research investigates the potential of low-dose loxapine (LOX) as a treatment option for ASD. The study examined the neuromotor tolerability of LOX in an outpatient sample of adolescents and adults with ASD, aiming to assess the potential of this medication for treating behavioral and other symptoms.

Loxapine: A New Oasis in the Desert of ASD Treatment?

The study suggests that LOX may be well-tolerated and could offer a new and potentially beneficial treatment option for individuals with ASD. This is encouraging, as it opens the door to new possibilities in the search for effective therapies for this complex disorder. It's like finding a hidden spring in the desert, offering a potential source of relief and hope for individuals with ASD and their families.

Navigating the Challenges of ASD Treatment

Further research is needed to determine the long-term safety and efficacy of LOX in treating ASD. It is important to continue exploring new avenues of treatment, as this research is like discovering a new route through the desert, paving the way for better understanding and care for individuals with ASD.

Dr. Camel's Conclusion

This research offers a promising new approach to treating ASD. While more research is needed, it is an encouraging sign that there may be new and effective treatment options on the horizon. The study is like finding a lone palm tree in the desert, providing shade and hope for a more fulfilling future for individuals with ASD.

Date :
  1. Date Completed 2016-09-27
  2. Date Revised 2015-10-21
Further Info :

Pubmed ID

26485086

DOI: Digital Object Identifier

10.1089/cap.2014.0145

Related Literature

Article Analysis
・Effects of loxapine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.